• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌中代谢调节性非编码 RNA:作用、机制及临床应用。

Metabolism-regulating non-coding RNAs in breast cancer: roles, mechanisms and clinical applications.

机构信息

Department of Clinical Laboratory, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215004, People's Republic of China.

Department of Oncology, The Second Affiliated Hospital of Soochow University, 1055 Sanxiang Road, Suzhou, Jiangsu, 215004, People's Republic of China.

出版信息

J Biomed Sci. 2024 Feb 26;31(1):25. doi: 10.1186/s12929-024-01013-w.

DOI:10.1186/s12929-024-01013-w
PMID:38408962
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10895768/
Abstract

Breast cancer is one of the most common malignancies that pose a serious threat to women's health. Reprogramming of energy metabolism is a major feature of the malignant transformation of breast cancer. Compared to normal cells, tumor cells reprogram metabolic processes more efficiently, converting nutrient supplies into glucose, amino acid and lipid required for malignant proliferation and progression. Non-coding RNAs(ncRNAs) are a class of functional RNA molecules that are not translated into proteins but regulate the expression of target genes. NcRNAs have been demonstrated to be involved in various aspects of energy metabolism, including glycolysis, glutaminolysis, and fatty acid synthesis. This review focuses on the metabolic regulatory mechanisms and clinical applications of metabolism-regulating ncRNAs involved in breast cancer. We summarize the vital roles played by metabolism-regulating ncRNAs for endocrine therapy, targeted therapy, chemotherapy, immunotherapy, and radiotherapy resistance in breast cancer, as well as their potential as therapeutic targets and biomarkers. Difficulties and perspectives of current targeted metabolism and non-coding RNA therapeutic strategies are discussed.

摘要

乳腺癌是最常见的恶性肿瘤之一,严重威胁着女性的健康。能量代谢的重编程是乳腺癌恶性转化的一个主要特征。与正常细胞相比,肿瘤细胞更有效地重新编程代谢过程,将营养供应转化为葡萄糖、氨基酸和脂质,以满足恶性增殖和进展的需要。非编码 RNA(ncRNAs)是一类不翻译成蛋白质但调节靶基因表达的功能 RNA 分子。ncRNAs 已被证明参与能量代谢的各个方面,包括糖酵解、谷氨酰胺分解和脂肪酸合成。本综述重点介绍了代谢调节 ncRNAs 在乳腺癌中的代谢调控机制及临床应用。我们总结了代谢调节 ncRNAs 在内分泌治疗、靶向治疗、化疗、免疫治疗和放射治疗抵抗中的重要作用,以及它们作为治疗靶点和生物标志物的潜力。讨论了当前靶向代谢和非编码 RNA 治疗策略的困难和展望。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08de/10895768/f1dd70277663/12929_2024_1013_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08de/10895768/71cda156424d/12929_2024_1013_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08de/10895768/b717b2260bdb/12929_2024_1013_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08de/10895768/9ba44d277c0e/12929_2024_1013_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08de/10895768/5555e6e86f6e/12929_2024_1013_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08de/10895768/f1dd70277663/12929_2024_1013_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08de/10895768/71cda156424d/12929_2024_1013_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08de/10895768/b717b2260bdb/12929_2024_1013_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08de/10895768/9ba44d277c0e/12929_2024_1013_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08de/10895768/5555e6e86f6e/12929_2024_1013_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08de/10895768/f1dd70277663/12929_2024_1013_Fig5_HTML.jpg

相似文献

1
Metabolism-regulating non-coding RNAs in breast cancer: roles, mechanisms and clinical applications.乳腺癌中代谢调节性非编码 RNA:作用、机制及临床应用。
J Biomed Sci. 2024 Feb 26;31(1):25. doi: 10.1186/s12929-024-01013-w.
2
The emerging regulatory roles of non-coding RNAs associated with glucose metabolism in breast cancer.与乳腺癌葡萄糖代谢相关的非编码 RNA 的新兴调控作用。
Semin Cancer Biol. 2023 Oct;95:1-12. doi: 10.1016/j.semcancer.2023.06.007. Epub 2023 Jun 25.
3
Non-coding RNAs: Key regulators of aerobic glycolysis in breast cancer.非编码 RNA:乳腺癌有氧糖酵解的关键调节因子。
Life Sci. 2020 Jun 1;250:117579. doi: 10.1016/j.lfs.2020.117579. Epub 2020 Mar 21.
4
Non-coding RNAs in the reprogramming of glucose metabolism in cancer.非编码 RNA 在癌症葡萄糖代谢重编程中的作用。
Cancer Lett. 2018 Apr 10;419:167-174. doi: 10.1016/j.canlet.2018.01.048. Epub 2018 Jan 31.
5
The role and mechanism of noncoding RNAs in regulation of metabolic reprogramming in hepatocellular carcinoma.非编码 RNA 在肝细胞癌代谢重编程调控中的作用及其机制。
Int J Cancer. 2022 Aug 1;151(3):337-347. doi: 10.1002/ijc.34040. Epub 2022 May 11.
6
Metabolic Pathways in Breast Cancer Reprograming: An Insight to Non-Coding RNAs.乳腺癌重编程中的代谢途径:非编码 RNA 的新视角。
Cells. 2022 Sep 23;11(19):2973. doi: 10.3390/cells11192973.
7
Role and mechanisms of noncoding RNAs in the regulation of metabolic reprogramming in bladder cancer (Review).非编码 RNA 在膀胱癌代谢重编程调控中的作用及机制(综述)。
Int J Mol Med. 2023 Sep;52(3). doi: 10.3892/ijmm.2023.5282. Epub 2023 Jul 21.
8
Non-coding RNAs derailed: The many influences on the fatty acid reprogramming of cancer.非编码 RNA 出轨:癌症脂肪酸重编程的多种影响。
Life Sci. 2019 Aug 15;231:116509. doi: 10.1016/j.lfs.2019.05.065. Epub 2019 May 29.
9
Emerging roles of non-coding RNAs in the metabolic reprogramming of tumor-associated macrophages.非编码RNA在肿瘤相关巨噬细胞代谢重编程中的新作用
Immunol Lett. 2021 Apr;232:27-34. doi: 10.1016/j.imlet.2021.02.003. Epub 2021 Feb 9.
10
Role of non-coding RNAs in response of breast cancer to radiation therapy.非编码 RNA 在乳腺癌对放射治疗的反应中的作用。
Mol Biol Rep. 2022 Jun;49(6):5199-5208. doi: 10.1007/s11033-022-07234-2. Epub 2022 Feb 25.

引用本文的文献

1
Regulatory Roles of miR-155-5p, miR-21-5p, miR-93-5p, and miR-140-5p in Breast Cancer Progression.miR-155-5p、miR-21-5p、miR-93-5p和miR-140-5p在乳腺癌进展中的调控作用
Curr Issues Mol Biol. 2025 May 20;47(5):377. doi: 10.3390/cimb47050377.
2
Mechanism of action and potential therapeutic targets of TGF-β-related signaling pathway and its downstream miRNA expression in pulmonary arterial hypertension.转化生长因子-β相关信号通路在肺动脉高压中的作用机制、潜在治疗靶点及其下游微小RNA表达
Front Pharmacol. 2025 Jun 6;16:1596767. doi: 10.3389/fphar.2025.1596767. eCollection 2025.
3
Targeting ncRNAs to overcome metabolic reprogramming‑mediated drug resistance in cancer (Review).

本文引用的文献

1
MicroRNA regulation of the serine synthesis pathway in endocrine-resistant breast cancer cells.微小 RNA 对内分泌抵抗型乳腺癌细胞丝氨酸合成途径的调控。
Endocr Relat Cancer. 2023 Sep 27;30(11). doi: 10.1530/ERC-23-0148. Print 2023 Nov 1.
2
Emerging therapies in cancer metabolism.癌症代谢中的新兴治疗方法。
Cell Metab. 2023 Aug 8;35(8):1283-1303. doi: 10.1016/j.cmet.2023.07.006.
3
MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategies.微小 RNA:癌症诊断和治疗策略临床试验的趋势。
靶向非编码RNA以克服癌症中代谢重编程介导的耐药性(综述)
Int J Oncol. 2025 May;66(5). doi: 10.3892/ijo.2025.5741. Epub 2025 Mar 21.
4
Circular RNAs as Biomarkers in Breast Cancer Diagnosis, Prognosis, Molecular Types, Metastasis and Drug Resistance.环状RNA作为乳腺癌诊断、预后、分子分型、转移和耐药性的生物标志物
Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251328500. doi: 10.1177/15330338251328500. Epub 2025 Mar 13.
5
LINC00899 suppresses the progression of triple-negative breast cancer via the miRNA-425/PTEN axis and is a biomarker for neoadjuvant chemotherapy efficacy.LINC00899通过miRNA-425/PTEN轴抑制三阴性乳腺癌的进展,是新辅助化疗疗效的生物标志物。
J Cancer. 2025 Feb 10;16(5):1647-1655. doi: 10.7150/jca.100619. eCollection 2025.
6
The role of ceRNAs in breast cancer microenvironmental regulation and therapeutic implications.ceRNAs在乳腺癌微环境调节中的作用及治疗意义。
J Mol Med (Berl). 2025 Jan;103(1):33-49. doi: 10.1007/s00109-024-02503-y. Epub 2024 Dec 6.
7
Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer.原发性和转移性乳腺癌中的代谢重编程和治疗抵抗。
Mol Cancer. 2024 Nov 21;23(1):261. doi: 10.1186/s12943-024-02165-x.
8
Non-metabolic enzyme function of pyruvate kinase M2 in breast cancer.丙酮酸激酶M2在乳腺癌中的非代谢酶功能
Front Oncol. 2024 Oct 1;14:1450325. doi: 10.3389/fonc.2024.1450325. eCollection 2024.
9
Visfatin Facilitates VEGF-D-Induced Lymphangiogenesis through Activating HIF-1α and Suppressing miR-2277-3p in Human Chondrosarcoma.内脂素通过激活 HIF-1α 和抑制 miR-2277-3p 促进人软骨肉瘤中 VEGF-D 诱导的淋巴管生成。
Int J Mol Sci. 2024 May 9;25(10):5142. doi: 10.3390/ijms25105142.
10
Small Non-Coding RNAs and Their Role in Locoregional Metastasis and Outcomes in Early-Stage Breast Cancer Patients.小型非编码 RNA 及其在早期乳腺癌患者局部区域转移和结局中的作用。
Int J Mol Sci. 2024 Apr 3;25(7):3982. doi: 10.3390/ijms25073982.
Exp Mol Med. 2023 Jul;55(7):1314-1321. doi: 10.1038/s12276-023-01050-9. Epub 2023 Jul 10.
4
EIF4A3-induced circZFAND6 promotes breast cancer proliferation and metastasis through the miR-647/FASN axis.EIF4A3 诱导的 circZFAND6 通过 miR-647/FASN 轴促进乳腺癌的增殖和转移。
Life Sci. 2023 Jul 1;324:121745. doi: 10.1016/j.lfs.2023.121745. Epub 2023 Apr 29.
5
An old friend with a new face: tRNA-derived small RNAs with big regulatory potential in cancer biology.旧友新颜:tRNA 衍生的小 RNA 在癌症生物学中具有巨大的调控潜力。
Br J Cancer. 2023 May;128(9):1625-1635. doi: 10.1038/s41416-023-02191-4. Epub 2023 Feb 9.
6
Exosomal lncRNA NEAT1 induces paclitaxel resistance in breast cancer cells and promotes cell migration by targeting miR-133b.外泌体长链非编码RNA NEAT1通过靶向miR-133b诱导乳腺癌细胞对紫杉醇耐药并促进细胞迁移。
Gene. 2023 Apr 15;860:147230. doi: 10.1016/j.gene.2023.147230. Epub 2023 Jan 27.
7
Long noncoding RNA DIO3OS induces glycolytic-dominant metabolic reprogramming to promote aromatase inhibitor resistance in breast cancer.长非编码 RNA DIO3OS 诱导糖酵解优势代谢重编程以促进乳腺癌对芳香化酶抑制剂耐药。
Nat Commun. 2022 Nov 22;13(1):7160. doi: 10.1038/s41467-022-34702-x.
8
miRNA-195-5p/PSAT1 feedback loop in human triple-negative breast cancer cells.人三阴性乳腺癌细胞中的miRNA-195-5p/PSAT1反馈环
Genes Genomics. 2023 Jan;45(1):39-47. doi: 10.1007/s13258-022-01327-9. Epub 2022 Nov 12.
9
Role of LDH in tumor glycolysis: Regulation of LDHA by small molecules for cancer therapeutics.LDH 在肿瘤糖酵解中的作用:小分子对 LDHA 的调节在癌症治疗中的作用。
Semin Cancer Biol. 2022 Dec;87:184-195. doi: 10.1016/j.semcancer.2022.11.007. Epub 2022 Nov 9.
10
N6-methyladenosine-modified circular RNA QSOX1 promotes colorectal cancer resistance to anti-CTLA-4 therapy through induction of intratumoral regulatory T cells.N6-甲基腺苷修饰的环状 RNA QSOX1 通过诱导肿瘤内调节性 T 细胞促进结直肠癌对抗 CTLA-4 治疗的耐药性。
Drug Resist Updat. 2022 Dec;65:100886. doi: 10.1016/j.drup.2022.100886. Epub 2022 Oct 21.